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The effects of group size and subtherapeutic antibiotic alternatives on growth 
performance and morbidity of nursery pigs: a model for feed additive evaluation 
Abstract 
The objectives of this experiment were to evaluate the effects of alternatives to antibiotic growth 
promoters (AGP), two group sizes, and their interaction on nursery pig performance to serve as a model 
for future AGP alternative studies. A 41-d experiment was conducted in a commercial wean-to-finish barn; 
1,300 piglets weaned at 21 d of age (weaned 2 or 4 d prior to experiment; 6.14 ± 0.18 kg BW; PIC 1050 
sows and multiple sire lines) were blocked by sire, sex, and weaning date, then assigned to eight 
treatments: four dietary treatments each evaluated across two group sizes. The four dietary treatments 
were: negative control (NC), positive control (PC; NC + in-feed antibiotics), zinc oxide plus a dietary 
acidifier (blend of fumaric, citric, lactic, and phosphoric acid) (ZA; NC + ZnO + acid), and a Bacillus-based 
direct-fed-microbial (DFM) plus resistant potato starch (RS) (DR; NC + DFM + RS). The two group sizes 
were 31 or 11 pigs/pen; floor space was modified so area/pig was equal between the group sizes (0.42 
m2/pig). There were 7 pens/diet with 11 pigs/pen and 8 pens/diet with 31 pigs/pen. Data were analyzed 
as a randomized complete block design with pen as the experimental unit. Diagnostic assessment of oral 
fluids, serum, and tissue samples was used to characterize health status. Pigs experienced natural 
challenges of acute diarrhea and septicemia in week 1 and porcine reproductive and respiratory 
syndrome virus (PRRSV) in weeks 4–6. There was a significant interaction between diet and group size 
for ADG (P = 0.012). PC increased ADG in large and small groups (P < 0.05) and ZA increased ADG only in 
large groups (P < 0.05). Small groups had improved ADG compared to large groups when fed NC or DR 
diets (P <</em> 0.05). Similarly, PC increased ADFI (P < 0.05). Compared to NC, ZA improved ADFI in 
large groups only (P < 0.05; diet × group size: P = 0.015). Pigs fed PC had greater G:F than NC (P < 0.05), 
and small groups had greater G:F than large groups (P < 0.05). There was no effect of ZA or DR on G:F. 
Pigs fed PC required fewer individual medical treatments than NC and pigs fed ZA were intermediate (P = 
0.024). More pigs were removed from large than small groups (P = 0.049), and there was no effect of diet 
on removals (P > 0.10). In conclusion, careful study design, protocol implementation, sample collection, 
and recording of important information allowed us to characterize the health status of this group of pigs 
and determine treatment effects on growth performance and morbidity. 
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The effects of group size and subtherapeutic antibiotic alternatives on growth 
performance and morbidity of nursery pigs: a model for feed additive evaluation1
Kristin M. Olsen,* Nicholas K. Gabler,* Chris J. Rademacher,† Kent J. Schwartz,†  
Wesley P. Schweer,* Gene G. Gourley,‡ and John F. Patience*,2 
*Department of Animal Science, Iowa State University, Ames, IA 50011; †Department of Veterinary Diagnostic 
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ABSTRACT: The objectives of this experiment were 
to evaluate the effects of alternatives to antibiotic 
growth promoters (AGP), two group sizes, and their 
interaction on nursery pig performance to serve as 
a model for future AGP alternative studies. A 41-d 
experiment was conducted in a commercial wean-
to-finish barn; 1,300 piglets weaned at 21 d of age 
(weaned 2 or 4 d prior to experiment; 6.14 ± 0.18 kg 
BW; PIC 1050 sows and multiple sire lines) were 
blocked by sire, sex, and weaning date, then assigned 
to eight treatments: four dietary treatments each 
evaluated across two group sizes. The four dietary 
treatments were: negative control (NC), positive con-
trol (PC; NC + in-feed antibiotics), zinc oxide plus 
a dietary acidifier (blend of fumaric, citric, lactic, 
and phosphoric acid) (ZA; NC + ZnO + acid), and 
a Bacillus-based direct-fed-microbial (DFM) plus 
resistant potato starch (RS) (DR; NC + DFM + RS). 
The two group sizes were 31 or 11 pigs/pen; floor 
space was modified so area/pig was equal between the 
group sizes (0.42 m2/pig). There were 7 pens/diet with 
11 pigs/pen and 8 pens/diet with 31 pigs/pen. Data 
were analyzed as a randomized complete block design 
with pen as the experimental unit. Diagnostic assess-
ment of oral fluids, serum, and tissue samples was 
used to characterize health status. Pigs experienced 
natural challenges of acute diarrhea and septicemia 
in week 1 and porcine reproductive and respiratory 
syndrome virus (PRRSV) in weeks 4–6. There was 
a significant interaction between diet and group size 
for ADG (P = 0.012). PC increased ADG in large 
and small groups (P < 0.05) and ZA increased ADG 
only in large groups (P  <  0.05). Small groups had 
improved ADG compared to large groups when fed 
NC or DR diets (P < 0.05). Similarly, PC increased 
ADFI (P < 0.05). Compared to NC, ZA improved 
ADFI in large groups only (P < 0.05; diet × group 
size: P = 0.015). Pigs fed PC had greater G:F than NC 
(P < 0.05), and small groups had greater G:F than 
large groups (P < 0.05). There was no effect of ZA 
or DR on G:F. Pigs fed PC required fewer individual 
medical treatments than NC and pigs fed ZA were 
intermediate (P = 0.024). More pigs were removed 
from large than small groups (P = 0.049), and there 
was no effect of diet on removals (P > 0.10). In con-
clusion, careful study design, protocol implementa-
tion, sample collection, and recording of important 
information allowed us to characterize the health 
status of this group of pigs and determine treatment 
effects on growth performance and morbidity.
Key words: antibiotic growth promoter, pen size, porcine reproductive and respiratory 
syndrome virus, swine
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INTRODUCTION
Consumer interest in pork raised without anti-
biotics or with limited antibiotics and the intro-
duction of the Veterinary Feed Directive in the 
United States have encouraged producers to look 
for alternatives to antibiotic growth promoters 
(AGP) in feed. There are many products already 
available that may be considered alternatives to 
AGP. However, the efficacy of AGP alternatives in 
commercial pork production has not been clearly 
defined, and the results of AGP alternative stud-
ies are often inconsistent (Jacela et al., 2009, 2010; 
Thacker, 2013; Liao and Nyachoti, 2017). This 
may be due to inconsistent experiment methodol-
ogy, including differences in health status, genet-
ics, experimental conditions, and diet composition 
(Allen et al., 2013). This leaves a significant gap in 
knowledge about the effectiveness of AGP alter-
natives and the ability to make comparisons or 
observe trends across studies. To most efficiently 
identify useful AGP alternatives and apply them in 
production, it is necessary first to increase the con-
sistency with which studies evaluating AGP alter-
natives are conducted. Therefore, there is a need for 
an example protocol with guidelines for AGP alter-
native studies.
Most published studies evaluating AGP alterna-
tives have been conducted in academic research set-
tings, which typically house fewer pigs per pen than 
commercial production facilities. Because group size 
may impact pig performance, specifically in the nurs-
ery phase (Wolter et  al., 2000), one may question 
whether the results of such studies could be differ-
ent in a commercial setting. Furthermore, inherent 
environmental differences between academic research 
facilities and commercial pork production facilities 
create the need for more commercial-scale data.
The objective of this experiment was to test the 
effects of two different group sizes and AGP alter-
native diets on nursery pig growth performance, in 
order to serve as a framework for future AGP alter-
native studies. This objective was selected to encour-
age greater progress in assessing the scientific merit 
of said studies as rapidly as possible and to facilitate 
the comparison of experimental results across mul-
tiple studies.
MATERIALS AND METHODS
All experimental procedures were reviewed and 
approved by the Iowa State University Institutional 
Animal Care and Use Committee (number 3-17-
8465-S). The study was conducted in central Iowa 
in April and May 2017.
Animals, Housing, and Management
One room of a commercial wean-to-finish 
research barn was populated with 1,300 barrows and 
gilts (6.14  ±  0.18  kg BW) derived from PIC 1,050 
females and four different sire lines (PIC Duroc, DNA 
Genetics Duroc, Genesus Duroc or PIC Pietrain) for 
a 42-d nursery study. The pigs were selected from a 
study evaluating sire lines, thus explaining the larger 
than normal number of sires represented in the experi-
ment. All pigs used in the experiment came from the 
same sow source and were weaned at 21 d of age. On 
day 1 after birth, all pigs were given iron and gen-
tamicin injections. Before weaning, pigs were treated 
on an individual basis with injectable antibiotics 
(gentamicin, ceftiofur, or enrofloxacin) as needed. At 
weaning, pigs were vaccinated for porcine circovirus 
type 2 and Mycoplasma hyopneumoniae (Circumvent 
PCV-MG2, Merck Animal Health, Madison, NJ), 
and ileitis (Porcilis Ileitis, Merck Animal Health). 
Due to the flow schedule at the sow source, approxi-
mately half of the pigs were weaned 4 d prior to the 
start of the experiment and held at the sow farm while 
the other half was weaned 2 d prior to the start of 
the experiment. For the duration of the experiment, 
pigs were housed in a tunnel-ventilated barn. Each 
pen was equipped with a 4-space automatic dry self-
feeder and nipple water drinker, fully slatted concrete 
floors, and metal rod penning and gates. Pigs were 
given ad libitum access to feed and water for the dur-
ation of the experiment. An automatic feeding system 
(Big Dutchman, Holland, MI) was used to deliver a 
specified amount of feed to each pen. Air temperature 
in the room averaged 28.5  °C ± 1.4, 28.7  °C ± 1.2, 
27.1 °C ± 0.5, 24.5 °C ± 1.1, 25.8 °C ± 0.9, 26.5 °C ± 
2.2, in weeks 1–6, respectively.
Experimental Design
Experimental treatments were arranged in a 
split-plot design with four dietary treatments eval-
uated across two group sizes. The dietary treat-
ments included a negative control (NC) with no 
AGP, a positive control (PC) consisting of  the NC 
diet with either chlortetracycline hydrochloride 
(phase 1 and 3)  or tiamulin hydrogen fumarate 
(phase 2)  added at the expense of  corn, alterna-
tive diet 1 (ZA) consisting of  the NC diet with 
zinc oxide (ZnO) plus a dietary acidifier (blend 
of  phosphoric, fumaric, citric, and lactic acids; 
Kem-Gest, Kemin, Des Moines, IA) added at the 
expense of  corn, and alternative diet 2 (DR) con-
sisting of  the NC diet with a Bacillus-based direct-
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Hoersholm, Denmark) plus resistant potato starch 
(MSP[RS], MSP Starch Products Inc., Carberry, 
Manitoba, Canada) added at the expense of  corn. 
Combinations of  AGP alternatives were used, 
rather than single products, to first help satisfy 
the objective of  testing a study design, rather than 
focusing on evaluating specific products. The spe-
cific combinations were chosen based on results 
from Schweer et  al. (2017a) which indicated that 
AGP alternatives in the categories of  zinc/copper, 
organic acids, and probiotics were most effective. 
Furthermore, ZnO with an acidifier and a probiotic 
Table 1. Ingredient and nutrient composition of experimental diets (as fed basis): phase 1 and 21
Phase 1 Phase 2
Dietary treatment2
NC PC ZA DR NC PC ZA DR
Ingredient, %
 Corn 34.24 33.94 33.64 29.19 52.80 52.62 52.40 47.75
 Soybean meal 47% CP 17.50 17.50 17.50 17.50 27.50 27.50 27.50 27.50
 Whey permeate 20.73 20.73 20.73 20.73 4.88 4.88 4.88 4.88
 Dried yeast 11.12 11.12 11.12 11.12 3.56 3.56 3.56 3.56
 Rolled oat groats 7.50 7.50 7.50 7.50 5.00 5.00 5.00 5.00
 Choice white grease 3.48 3.48 3.48 3.48 3.48 3.48 3.48 3.48
 Spray-dried plasma 3.00 3.00 3.00 3.00 — — — —
 Limestone 0.70 0.70 0.70 0.70 0.69 0.69 0.69 0.69
 L-lysine HCl 0.51 0.51 0.51 0.51 0.48 0.48 0.48 0.48
 MHA methionine 0.35 0.35 0.34 0.34 0.35 0.35 0.35 0.35
 Monocalcium phosphate 0.31 0.31 0.31 0.31 0.54 0.54 0.54 0.54
 VTM premix3 0.18 0.18 0.18 0.18 0.18 0.18 0.18 0.18
 Salt 0.15 0.15 0.15 0.15 0.28 0.28 0.28 0.28
 Choline 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12
 L-Threonine 0.08 0.08 0.08 0.08 0.16 0.16 0.16 0.16
 L-Tryptophan 0.03 0.03 0.03 0.03 — — — —
 CTC4 — 0.30 — — — — — —
 Tiamulin4 — — — — — 0.18 — —
 Zinc oxide — — 0.30 — — — 0.20 —
 Acidifier5 — — 0.30 — — — 0.20 —
 DFM6 — — — 0.05 — — — 0.05
 Potato Starch7 — — — 5.00 — — — 5.00
Analyzed values
 Resistant starch,8 % — — — 1.89 — — — 1.82
 DM% 89.0 88.8 89.0 88.8 87.6 87.7 87.3 87.3
 Ether extract, % 5.60 5.96 6.04 5.76 6.06 6.45 6.13 6.14
 Ca, % 0.68 0.72 0.64 0.72 0.59 0.61 0.57 0.61
 P, % 0.61 0.62 0.63 0.60 0.51 0.53 0.51 0.52
 Na, % 0.30 0.31 0.30 0.31 0.15 0.15 0.16 0.16
 CP, % 21.00 21.60 20.40 21.00 19.60 19.80 19.10 19.00
 Zinc, ppm 461 347 1900 459 432 357 1160 406
1Phase 1 was fed from days 0 to 11, phase 2 was fed from days 12 to 24. Feed budget was 2.2 kg/pig for phase 1 and 5.4 kg/pig for phase 2.
2NC = negative control, PC = positive control: NC + dietary antibiotics, ZA = NC + ZnO + dietary acidifier, DR = NC + Bacillus-based direct-
fed microbial + 5% resistant starch.
3VTM premix provided per kg of complete diet: 0.21 ppm Cr as Cr2O3, 10 ppm Cu as CuSO4, and Cu-MHA chelate, 0.31 ppm I as calcium 
iodate, 82 ppm Fe as FeSO4, 21 ppm Mn as MnO and Mn-MHA chelate, 0.31 ppm Se as selenium yeast, 170 ppm Zn as ZnO and Zn-MHA chelate, 
1,701 IU vitamin D3, 11,337 IU vitamin A, 45.3 IU vitamin E, 4.53 mg menadione, 0.23 mg biotin, 1.7 mg folic acid, 51 mg niacin, 15.6 mg pyridox-
ine, 28.3 mg pantothenic acid, 8.5 mg riboflavin, 39.7 mg vitamin B12, 514.4 FTU phytase (AxtraPhy, Danisco Animal Nutrition, Marlborough, 
UK). Premix also contained per kg of complete diet 0.06 g of Bacillus-based direct-fed-microbial (1.6 × 103 CFU/g).
4CTC  =  chlortetracycline hydrochloride (Auromycin-100, Zoetis, Parsippany, NJ); Tiamulin hydrogen fumarate (Denagard 10, Elanco, 
Greenfield, IN).
5Blend of phosphoric, fumaric, citric, and lactic acids (Kem-Gest, Kemin, Des Moines, IA).
6Bacillus spp. based direct-fed-microbial, provided 1.1 × 106 CFU/g of complete diet (BioPlus 2B, Chr. Hansen, Hoersholm, Denmark).
7Resistant potato starch (MSP[RS], MSP Starch Products Inc., Carberry, Manitoba, Canada).
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with a prebiotic likely have modes of  action which 
either compliment or do not antagonize each other. 
Diets were fed in three phases (Tables  1 and 2) 
based on a feed budgeting system. When a pen 
consumed its entire allowance for a phase, feed for 
the next phase was given to that pen. In this man-
ner, all pens were allowed to consume their entire 
budget for each phase before moving to the next 
phase. In order to associate pig weights with phase 
changes, weigh days were scheduled as close as 
possible to the first pens finishing their feed budget 
from the previous phase. Phase 1 was fed from days 
0 to 11, phase 2 from days 12 to 24, and phase 3 
from days 25 to 41.The first two phases were deliv-
ered in pelleted form, and the third phase feed was 
delivered as a mash. Feed was manufactured at two 
different commercial feed mills (phases 1 and 2 at 
the same mill, and phase 3 at another mill). Prior 
to diet manufacturing, the acidifier, ZnO, DFM, 
and RS products were hand-weighed on an ana-
lytical scale to the proper inclusion level, packaged 
in individual bags, and delivered to the commercial 
mill. Mix sheets used during mixing from both feed 
mills were validated after mixing to ensure that 
these bags were added to the proper batches. In all 
phases, the diet containing the DFM was mixed 
last in order to avoid contamination of  the other 
three diets.
Pigs were housed in groups of 31 (large groups; 
Fig.  1) or 11 pigs each (small groups; Fig.  2). In 
the small groups, a gate was installed to block off  
approximately two-thirds of the pen to reduce usa-
ble floor space; the two outer spaces of the feeders 
were blocked off  to achieve approximately equal 
feeder space per pig. Not counting the space occu-
pied by each feeder, large pens had 0.41 m2 per 
pig, and small pens had 0.42 m2 per pig. Sixty pens 
were utilized for a total of 15 replicates of each diet 
(eight large groups and seven small groups each), 
32 replicates of large groups and 28 replicates of 
small groups. Pigs were assigned to blocks based 
on weaning date, sire line, and sex. Pigs held for 4 
d or 2 d post-weaning were balanced within block 
to account for the potential influence of days 
post-weaning. Since four different sire lines were 
used, sire line was balanced within block. Mixed-
sex pens were used, and sex was balanced within 
block. A total of 8 blocks were used, and pens were 
assigned to experimental treatments so that each 
combination of diet and group size was represented 
in each block. However, since there were only 60 
pens, one block had only four large groups and no 
small groups.
Table  2. Ingredient and nutrient composition of 
experimental diets (as fed basis): phase 31
Dietary Treatment2
NC PC ZA DR
Ingredient, %
 Corn 47.59 47.19 47.29 42.54
 Soybean meal 46.5% CP 35.95 35.95 35.95 35.95
 Corn DDGS 10.00 10.00 10.00 10.00
 Choice white grease 3.20 3.20 3.20 3.20
 Limestone 1.03 1.03 1.03 1.03
 Lysine sulfate, 54.6% 0.67 0.67 0.67 0.67
 Monocalcium phosphate 0.54 0.54 0.54 0.54
 Salt 0.46 0.46 0.46 0.46
 DL-Methionine 0.19 0.19 0.19 0.19
 VTM premix3 0.15 0.15 0.15 0.15
 L-Threonine 0.13 0.13 0.13 0.13
 Vitamin E 0.05 0.05 0.05 0.05
 L-Tryptophan 0.04 0.04 0.04 0.04
 Phytase4 0.01 0.01 0.01 0.01
 CTC5 — 0.40 — —
 Zinc oxide — — 0.10 —
 Acidifier6 — — 0.20 —
 DFM7 — — — 0.05
 Potato starch8 — — — 5.00
Analyzed values
 Resistant starch,9 % — — — 3.90
 DM, % 88.4 88.5 88.3 87.9
 Ether extract, % 6.73 6.04 5.95 5.69
 Ca, % 0.67 0.75 0.71 0.68
 P, % 0.60 0.61 0.60 0.58
 Na, % 0.21 0.26 0.22 0.21
 CP, % 24.2 24.3 24.2 23.9
 Zinc, ppm 138 196 701 240
1Phase 3 was fed from days 25 to 41.
2NC = negative control, PC = positive control: NC + dietary antibi-
otics, ZA = NC+ ZnO + dietary acidifier, DR = NC + Bacillus-based 
direct-fed microbial + 5% resistant starch.
3Vitamin–trace mineral premix provided per kg of complete diet: 
11,013 IU of vitamin A, 1,651 IU of vitamin D, 33 IU of vitamin E 
(dl-alpha tocopheryl acetate), 11 IU of vitamin E (d-alpha tocopheryl 
acetate), 4.4 mg of vitamin K, 0.029 mg of vitamin B12, 5.51 mg of 
riboflavin, 38.55 mg of niacin, 22.03 mg of pantothenic acid, 0.22 mg 
of biotin, 1.10 mg of folic acid, 0.88 mg of pyridoxine, 0.396 mg of Co 
as CoCO3, 0.015 g of Cu as CuO or CuSO4, 0.22 mg of I as ethylenedi-
amine dihydroiodide (EDDI) or CaI2, 0.15 g of Fe as FeSO4, 0.031 g of 
Mn as MnO or MnSO4, 0.31 mg of organic Se as selenium yeast, and 
0.15 g of Zn as ZnO or ZnSO4.
4OptiPhos 2000 (Huvepharma Inc., Peachtree City, GA).
5Chloratetracycline hydrochloride (Chlormax 50, Alpharma, 
Bridgewater Township, NJ).
6Blend of lactic, citric, fumaric, and phosphoric acids (Kem-Gest, 
Kemin, Des Moines, IA).
7Bacillus spp. based direct-fed-microbial product, provided 1.1 × 106 
CFU/g of complete diet (BioPlus 2B, Chr. Hansen, Hoersholm, 
Denmark).
8Resistant potato starch (MSP[RS], MSP Starch Products Inc., 
Carberry, Manitoba, Canada).
9Diets with no value did not have high enough resistant starch con-
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Figure 1. Large pen configuration. Pens were stocked with 31 pigs 
(0.41 m2 per pig).
Figure 2. Small pen configuration. Pens were stocked with 31 pigs 
(0.42 m2 per pig).
Characterization of Health Status
The pigs originated from a sow source that was 
negative for porcine reproductive and respiratory 
syndrome virus (PRRSV; confirmed through nega-
tive oral fluid and serum PCR analysis). Oral fluids, 
serum samples, and necropsies of pigs that died 
were used to confirm or rule out exposure to specific 
pathogens (Table  3). All diagnostic tests, includ-
ing necropsies, were conducted at the Veterinary 
Diagnostics Laboratory at Iowa State University in 
Ames, Iowa. If  a sample was positive for a specific 
pathogen, the whole barn was considered to have 
exposure to that pathogen.
Under the direction of a veterinarian, pigs 
were individually treated throughout the study with 
injectable antibiotics (ceftiofur or enrofloxacin) for 
symptoms of lethargy, gauntness, severe diarrhea, 
coughing, or other signs of illness. Flunixamine was 
also given for a small number of cases of coughing 
and labored breathing. Individual medical treat-
ments were recorded daily by pen to determine if  
diet and group size influenced the number of treat-
ments required. Pigs were removed from the study 
and housed in a hospital pen if  they were injured, 
extremely ill, or did not improve after treatment. 
The daily number of pigs removed was recorded 
by pen. Pigs found dead were also recorded and 
included in the daily removal records.
Oral fluid samples were collected via rope sam-
pling from two pens per dietary treatment (eight 
pens total) on days 0, 21, and 40. Pens were cho-
sen for oral fluid collection based on fixed special 
sampling, so that each area of the barn was equally 
represented (Rotolo et al., 2017). A cotton rope was 
hung in the pen for approximately 1 h, and fluid was 
extracted from the rope by placing the saturated 
end into a plastic bag and squeezing out the fluid 
(Prickett et  al., 2008). The resulting fluid samples 
Table  3. Results of diagnostic testing throughout 
experiment (days 0 to 41)
Day1 Pathogen2 Result3 Testing method4
3 Salmonella (S. infantitis) Positive Liver culture
3 Actinobacillus suis Positive Lung culture
3 Streptococcus suis Positive Lung culture
11 Mycoplasma hyorhinis Positive Fibrin swab PCR
26 PRRSV Positive Oral fluid PCR
26 IAV Negative Oral fluid PCR
26 Streptococcus suis Positive Lung culture
26 Haemophilus parasuis Positive Lung culture
40 PEDV Negative Oral fluid PCR and 
serology
40 PDCoV Negative Oral fluid PCR
40 Mycoplasma 
hyopneumoniae
Negative Oral fluid PCR and 
serology
1Day of sample collection.
2PRRSV  =  porcine reproductive and respiratory syndrome virus, 
IAV  =  influenza A  virus, PEDV  =  porcine epidemic diarrhea virus, 
PDCoV = porcine deltacoronovirus.
3Samples were collected at necropsy from pigs that died as deter-
mined necessary by the diagnostic veterinarian. On day 26, oral fluid 
samples from four symptomatic pens were collected and tested. On 
day 40, oral fluid and serum samples from eight pens, equidistantly 
spaced throughout the barn, were collected and tested. If  a sample was 
positive for a specific pathogen, the whole barn was considered to have 
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were transferred to a plastic tube and stored at 
−20 °C until analysis. Oral fluid samples were ana-
lyzed using polymerase chain reaction (PCR) for 
PRRSV, Influenza type-A virus of swine (IAV-S), 
porcine epidemic diarrhea virus (PEDV), porcine 
deltacoronovirus (PDCoV), and M.  hyopneumo-
niae. Oral fluid samples were also collected from 
four pens exhibiting clinical symptoms (cough-
ing, sneezing, lethargy) and tested for PRRSV and 
IAV-S on day 26. Blood samples were collected from 
one pig per pen in two pens per dietary treatment 
(using the same pens as oral fluid collections) for a 
total of eight blood samples on days 1 and 28. At 
the end of the trial (day 41), eight pigs per dietary 
treatment (one pig from each of the large pens) were 
euthanized for a separate experiment and blood was 
collected from each. Ten milliliters of blood were 
collected by jugular venipuncture and centrifuged at 
2,000 × g for 10 min at 4 °C, and the resulting serum 
was stored at −80 °C for later analysis. Serum sam-
ples from day 41 were tested for PEDV and M. hyo-
pneumoniae using PCR. The goal of this diagnostic 
testing was to establish a general knowledge of dis-
ease exposure and health status of the pigs used in 
the study.
Diet Sample Analysis
Feed samples were taken directly from the feed-
ers of  eight pens per dietary treatment during the 
middle of  each feeding phase. To obtain each sam-
ple, the feed in each feeder was stirred to assist in 
homogeneity, and an approximately 200 g sample 
was taken by hand. All eight samples for each diet-
ary treatment were then pooled and homogenized, 
and subsamples were taken from this composite 
sample and stored at −20 °C prior to analysis. Diet 
samples were analyzed for DM (method 930.15), 
CP (method 990.03), ether extract (method 945.16), 
and Zn, Ca, P, and Na (method 985.01) at a com-
mercial laboratory (Midwest Laboratories, Omaha, 
Nebraska, AOAC, 2007). Bacillus-spore enumer-
ation in diet samples was performed at Midwest 
Laboratories using the Bacillus heat shock method 
(Jackson, 2015). Diets were analyzed for resistant 
starch (RS) content using a commercially avail-
able kit (Megazyme, Wicklow, Ireland; method 
2002.02, AOAC 2007). The goal of  analyzing diet 
samples for Bacillus, Zn, and RS was to confirm 
the presence of  the additives in the final mixed 
diets. Diets were not analyzed for the inclusion of 
the acid blend due to the current unavailability of 
an assay to quantify the specific acids included in 
the blend.
Growth Performance Data Collection
Pigs were weighed by pen on a floor scale (val-
idated with a standard check weight at each use) 
at the beginning and end of the experiment, and 
at the end of each feed phase (days 11 and 24) to 
determine ADG. Feed offered was weighed by the 
automatic feed delivery system, and remaining feed 
was weighed at the end of each phase to determine 
ADFI and G:F, measured as total BW gain:total 
feed intake. Pen, removal date, BW at removal, and 
reason for removal were recorded for each pig found 
dead or removed from the study. This information 
was used to calculate pig days for each phase and 
the overall experimental period.
Calculations and Statistical Analysis
The total number of medical treatments per 
pen was calculated as a proportion by dividing the 
total number of treatments given for the whole 
experimental period by the number of pigs placed 
in the pen (either 31 or 11). The proportion of total 
removals per pen was calculated by dividing the 
total number of pigs removed for the whole period 
in each pen by the number of pigs placed in the pen 
(either 31 or 11). Pig days were used to calculate 
ADG, ADFI, and G:F.
The UNIVARIATE procedure of SAS (SAS 
Inst. Inc. Cary, NC) was used to determine homo-
geneity of variances and to identify outliers. 
Observations were considered outliers if  greater 
than three SD from the mean. Residual plots were 
also used to verify equality of variances and nor-
mality of the residuals. It was determined that all 
variables analyzed met the assumptions for para-
metric tests, so the same model was used to ana-
lyze all the data. The MIXED procedure of SAS 
was used to analyze the data with pen as the experi-
mental unit and initial BW as a covariate. The fixed 
effects were diet, group size, and diet × group size 
interaction. Block was considered a random effect. 
Differences were considered significant if  P < 0.05 
and tendencies if  0.05 ≥ P < 0.10.
RESULTS
Diet Analysis
Results of Zn and RS analysis confirmed their 
presence in the complete feed in their respective diet-
ary treatments (Tables 1 and 2). With respect to the 
DFM product, after the experiment was completed, 
it was discovered that a separate Bacillus-based 
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Table 4. Effects of dietary treatment and group size, and their interaction, on nursery pig growth perfor-
mance, day 0–41
Treatment1
Large group Small group P value
Item, kg NC PC ZA DR NC PC ZA DR SEM Diet Group size Diet × group size
Start BW 6.12 6.11 6.11 6.12 6.09 6.09 6.09 6.08 0.089 0.997 0.013 0.958
End BW 17.32 20.13 18.25 17.16 18.46 20.01 17.94 17.69 0.361 <0.001 0.154 0.080
ADG 0.26 0.33 0.28 0.25 0.29 0.33 0.27 0.28 0.009 <0.001 0.006 0.012
ADFI 0.40 0.47 0.43 0.40 0.43 0.47 0.42 0.42 0.011 <0.001 0.144 0.015
G:F 0.64 0.69 0.65 0.62 0.67 0.69 0.66 0.66 0.010 <0.001 0.004 0.203
1NC = negative control; PC = positive control: NC + dietary antibiotics; ZA = NC + ZnO + dietary acidifier; DR = NC + Bacillus-based direct-
fed microbial + 5% resistant starch. Group size treatments: pigs were housed in groups of either 31 (large group) or 11 (small group) pigs per pen.
used at the commercial feed mill that manufactured 
the phase 1 and 2 diets; thus, a DFM product had 
been added to all phase 1 and 2 diets. Consequently, 
Bacillus spore counts were much higher than 
expected, although they were also quite variable 
(data not shown). In the phase 1 and 2 diets, Bacillus 
counts in the DR diet were not as high as expected; 
recovery varied from 20 to 60% of expected when 
taking into account both the DFM in the premix 
and the added DFM in the DR diet. Additionally, 
there was a low recovery of Bacillus in the DR diet 
from phase 3, but spore counts were elevated in this 
diet compared to the NC, PC, and ZA diets. The 
Bacillus product was tested and confirmed to con-
tain viable spores very close to the level specified on 
the product label (91% recovery). All test products 
were preweighed and the correct amounts per batch 
were delivered to the feed mills to ensure they were 
added at the correct quantity. Evaluation of the mix 
sheets confirmed that these preweighed bags were 
indeed added. We cannot explain why the assayed 
spore counts fell short of expected, other than per-
haps the difficulty of assaying low concentrations in 
complete feed, as compared to a premix.
Growth Performance
Due to naturally occurring health challenges 
reported below, overall pig performance was below 
that expected for this facility (Table 4).
For the overall period (days 0–41), there were 
impacts of both dietary treatment and group size, 
and their interaction, on piglet growth performance. 
There was an interaction between diet and group 
size for ADG (P = 0.012) and ADFI (P =0.015). 
Pigs fed the PC had higher ADG and ADFI than 
the NC for both group sizes (P < 0.05), and pigs 
fed the ZA diet only had a higher ADG and ADFI 
than the NC in the large groups (P < 0.05). Small 
groups fed the NC and DR diets had higher ADG 
compared to large groups fed these diets (P < 0.05). 
However, small and large groups had similar ADG 
for the PC and ZA diets (P > 0.05). The mean ADG 
for large groups was 0.280 kg and was 0.293 kg for 
small groups (main effect P = 0.006). Small groups 
had similar ADFI to large groups except for the 
NC control diet where small groups had higher 
ADFI (P < 0.05). There was no interaction between 
diet and group size for G:F; pigs fed the PC diet 
were more efficient than pigs fed the NC, ZA, and 
DR diets (diet P < 0.001), and small groups were 
more feed efficient than large groups (group size 
P = 0.004). There was no impact of the DR diet on 
growth performance (P > 0.05).
Within the individual feeding phases, perfor-
mance responses for diet and group size treatments 
showed similar patterns to the overall treatment 
data (data not shown). In phases 1 and 3, no inter-
actions between diet and group size were observed 
(P > 0.05). The main effect of group size was not 
significant for ADG, ADFI, or G:F in phases 1 and 
2 (P > 0.10) but was significant in phase 3 where 
small groups had greater ADG and G:F than large 
groups (P < 0.01). The main effect of diet was pres-
ent in all phases in a similar pattern to the overall 
results. In phase 3, ADG and G:F were similar to 
phase 2, which likely reflects depressions in growth 
performance due to PRRSV.
Animal Health and Morbidity
The pigs experienced acute diarrhea and sep-
ticemia in the first week of the experiment and a 
PRRSV challenge in the fourth week of the experi-
ment (confirmed by PCR analysis of oral fluids on 
day 26; Table  3). Mortality was 1.8%, and mor-
bidity (pigs removed from the study for illness or 
injury) was 6.1%. Mortality was not statistically 
analyzed due to the low numbers in each treatment. 






/tas/article/2/3/298/5049815 by guest on 02 February 2021
305Evaluation of antibiotic alternatives
Translate basic science to industry innovation
follows: NC diet, 8; PC diet, 3; ZA diet, 7; DR diet, 
6; large groups: 18; small groups: 6.
On day 5, all pigs were given gentamicin through 
the drinking water for 6 d to treat the diarrhea. 
Culture of liver and lung tissue from pigs that died 
during this time confirmed exposure to Salmonella 
(S. infantitis), Actinobacillus suis, and Streptococcus 
suis. Several deaths due to mulberry heart disease 
prompted water treatment with vitamin E and sele-
nium for 5 d (days 15 to 19). A PRRSV challenge 
was confirmed on day 26 of the study after obser-
vations of lethargy, heavy breathing, coughing, 
sneezing, and decreased feed intake. Pigs were indi-
vidually treated as described in the materials and 
methods section for symptoms for the remainder of 
the study. A timeline and result of all necropsies are 
listed in Table 5; results of all diagnostic testing are 
listed in Table 3.
There were no interactions between diet and 
group size for medical treatments or removals, 
so only main effects are presented (Table  6). Pigs 
fed the PC diet required fewer medical treatments 
than pigs fed the NC or DR diet, and the ZA diet 
was intermediate between NC and PC (P = 0.024). 
There was no effect of group size on number of 
medical treatments (P  =  0.706). The number of 
pigs removed from the study, including mortality 
and morbidity, was not influenced by dietary treat-
ment. However, the number of removals was lower 
in small groups than in large groups (P = 0.049).
DISCUSSION
The swine industry is seeking effective alterna-
tives to AGP, and inconsistent results from AGP 
alternative studies has led to the need for evaluating 
AGP alternative testing protocols and study designs. 
The objective of this experiment was to evaluate the 
effects of AGP alternative diets and test group size 
on nursery pig performance. These data can then 
Table 6. Effects of dietary treatment and group size on medical treatments and removals, day 0–41
Diet1 Group Size2
Item NC PC ZA DR SEM P value Large Small SEM P value
Medical treatments, 
proportion3,5
0.814a 0.506b 0.719ab 0.923a 0.152 0.024 0.759 0.722 0.136 0.706
Removals, proportion4,5 0.086 0.062 0.073 0.059 0.017 0.666 0.087 0.053 0.0121 0.0486
1NC = negative control; PC = positive control: NC + dietary antibiotics; ZA = NC+ ZnO + dietary acidifier; DR = NC + Bacillus-based direct-
fed microbial + 5% resistant starch.
2Group size treatments: pigs were housed in groups of either 31 (large group) or 11 (small group) pigs per pen.
3Medical treatments calculated as total number of medical treatments administered per pen divided by number of pigs allotted to pen (31 or 11).
4Removals calculated as total number of pigs removed from study (found dead or removed for illness or injury) divided by number of pigs allot-
ted to pen (31 or 11).
5Means within a row without a common superscript differ significantly (P < 0.05). Interaction P value for medical treatments and removals not 
significant. (P > 0.10).
Table 5. Timeline of necropsies and diagnostic results
Day Treatment1 Diagnosis Pathogens confirmed present2
3 DR, large group Pneumonia, septicemia Salmonella, Actinobacillus suis, Streptococcus suis
4 ZA, small group Pneumonia, septicemia —
5 ZA, large group Mulberry heart disease —
5 PC, large group Pneumonia, septicemia —
11 ZA, large group Pneumonia, septicemia Mycoplasma hyorhinis
11 DR, large group Pneumonia, meningitis —
13 NC, large group Mulberry heart disease —
17 ZA, large group Pneumonia, septicemia —
17 ZA, large group Mulberry heart disease —
26 NC, large group PRRSV, interstitial pneumonia Streptococcus suis, PRRSV
26 DR, large group PRRSV, interstitial pneumonia Streptococcus suis, PRRSV
38 PC, small group Intestinal torsion —
1NC = negative control; PC = positive control: NC + dietary antibiotics; ZA = NC+ ZnO + dietary acidifier; DR = NC + Bacillus-based direct-
fed microbial + 5% resistant starch. Group size treatments: pigs were housed in groups of either 31 (large group) or 11 pigs per pen (small group).
2Further testing for specific pathogens at necropsy was done at the discretion of the veterinarian.
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be used to provide a better framework of standards 
that can be used as a model for future studies testing 
the efficacy of AGP alternatives that will aid in com-
paring and interpreting results across those studies. 
The majority of published studies evaluating alter-
natives to AGP have been conducted in academic 
research settings, and consequently, most studies 
have used relatively small groups of pigs (Schweer 
et  al., 2017a). The literature review conducted by 
Schweer et al. (2017a) showed that experiments with 
a positive response to an AGP alternative had, on 
average, more pigs per pen than studies that did not 
show a positive response. The observed interactions 
between diet and group size indicate that consid-
eration of group size may be necessary in studies 
evaluating AGP alternatives. Improvements in per-
formance due to the ZA diet were only detected 
when pigs were housed in large groups. Higher 
removal rates were observed when pigs were housed 
in large groups, possibly indicating a higher-stress 
environment. These results may suggest a greater 
potential for this combination of additives to be 
effective under higher-stress situations, which may 
occur in larger group sizes. Furthermore, the bene-
fit of AGP seemed smaller when pigs were housed 
in small groups. Small groups fed the NC and DR 
diets had increased ADG compared to large groups. 
The PC and ZA diets seemed to somewhat com-
pensate for slower gain in large groups as small 
and large groups had similar ADG when fed these 
diets. Improved growth performance when pigs are 
housed in smaller groups is in agreement with pre-
vious reports of this trend in nursery pigs (Wolter 
et al., 2000, 2001). McGlone and Newby (1994) also 
reported higher morbidity rates in pens of 40 pigs 
compared to pens of 10 or 20. These results indicate 
that group size may impact the outcomes of AGP 
alternative studies, and perhaps positive responses 
to specific AGP alternatives are less pronounced in 
studies where pigs are housed in smaller groups.
The growth-promoting effects of subtherapeu-
tic levels of antibiotics in swine diets are well docu-
mented (Cromwell, 2002). Improvements in ADG, 
ADFI, and G:F observed in this study due to AGP 
inclusion are similar in magnitude to previous reports 
(Cromwell, 2002). The current improvements are 
higher than the values reported by Dritz et al. (2002) 
which could be due to the poor performance of the 
NC treatment, perhaps due to health status. It should 
also be noted that the chlortetracycline inclusion 
level in the present diets is higher than some previous 
studies have used, but the levels of antibiotics used 
in this study were compliant with the 2017 VFD for 
this particular farm. Separately, ZnO and acidifiers 
have shown beneficial effects, yet results have been 
inconsistent; few studies have looked at these in com-
bination. Pharmacological levels of Zn have also 
proven effective in improving growth performance 
of nursery pigs, in addition to decreasing diarrhea 
(Pettigrew, 2006; Heo et al., 2010; Pérez et al., 2011; 
Pluske, 2012). Walsh et al. (2007) and Li et al. (2008) 
both reported improvements in growth performance 
of nursery pigs due to acidifiers, though Boas et al. 
(2016) reported no improvements. Schweer et  al. 
(2017a) reported that acidifiers resulted in ADG 
improvements in 33.8% of studies.
Inclusion of DFM’s has also given inconsistent 
responses. Kyriakis et al., (1999), Papatsiros et al. 
(2011), and Hu et  al., (2014) reported improved 
growth performance, but many studies have also 
reported no improvements (Bhandari et al., 2008; 
Liao and Nyachoti, 2017). Resistant potato starch 
as a prebiotic has been shown to reduce diarrhea 
(Bhandari et  al., 2009), and in combination with 
a DFM has also improved ADG (Krause et  al., 
2010). However, studies evaluating resistant potato 
starch are uncommon.
It is clear that the PRRSV challenge impacted 
the performance of this group of pigs. Based on the 
standard feed budget used at this farm, expected 
feed intake during phase 3 would be 1.0–1.2  kg/
pig/day. Pigs consumed, on average, only 0.52 kg/
pig/day during this period. Compared to estimates 
from NRC (2012) for 11–25 kg pigs, the pigs gained 
46% less and ate 45% less per day. However, in 
phases 1 and 2, prior to the PRRSV outbreak, pigs 
performed as expected (0.212  kg/day compared 
to the 0.21  kg/day estimate for 5–7  kg pigs, and 
0.31 kg/day compared to the 0.34 kg/day estimate 
for 7–11  kg pigs; NRC, 2012). Severely reduced 
feed intake and low growth rate demonstrates the 
impact of the PRRSV challenge on growth perfor-
mance, which is typical for pigs challenged with this 
virus (Schweer et  al., 2017b). The present results 
were likely influenced by this health challenge, espe-
cially in phase 3 when pigs were consuming far less 
feed than expected and therefore were not receiving 
the desired amount of the AGP alternatives, poten-
tially decreasing their effect.
Pigs fed the PC diet required almost 40% fewer 
medical treatments, suggesting that AGP were 
beneficial to pig health and welfare during a dis-
ease challenge. The number of medical treatments 
required when pigs were fed the ZA diet was inter-
mediate between the NC and PC diets, indicating 
that this diet may have also benefited pig health. 
Few studies report medical treatments, but Pérez 
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the number of required medical treatments for pigs 
fed ZnO during a pathogenic E. coli challenge.
Considerations for Future Studies
There are likely many factors responsible for the 
inconsistent responses observed in studies evaluat-
ing AGP alternatives (Allen et al., 2013; Thacker, 
2013). To increase the value of future studies, it 
will be highly beneficial to provide more informa-
tion on study conditions than has previously been 
the case. When such information is provided, the 
context of the study will be more apparent, and it 
will be much easier to compare studies conducted 
in different locations and in different environments. 
Figure 3 outlines proposed necessary components 
that should be included and reported in AGP alter-
native studies. The remainder of this discussion will 
elaborate on a few specific components.
Health status is an important consideration 
when alternatives are being evaluated, as prod-
ucts may have greater or less efficacy under certain 
health conditions. Some evidence exists to suggest 
that AGP are more effective on commercial farms 
than in academic-type research settings (Cromwell, 
2002; Dritz et al., 2002), and this has been hypothe-
sized to be partially due to lower pathogen load and 
incidences of “subclinical” disease (Zimmerman, 
1986). If  health status can affect the response to 
AGP, then it is logical to propose that it could also 
influence the effects of AGP alternatives as well.
Indeed, health status has been discussed repeat-
edly as a potential reason for inconsistencies in 
response to AGP alternatives (Allen et al., 2013; Boas 
et al., 2016). Some studies have shown the potential 
for AGP alternatives to mitigate a health challenge 
(Bhandari et al., 2008; Gebru et al., 2010; Heo et al., 
2010); benefits of AGP alternatives to animal health 
during a disease challenge would be of great interest 
to the swine industry. Thus far, the impact of specific 
AGP alternatives in the presence of particular path-
ogens is not well understood, and information about 
health status is mostly absent in published AGP alter-
native studies (Schweer et al., 2017a). Documentation 
of the pathogens present in a group of pigs that may 
influence the outcome of a study will help to build 
an understanding of how AGP alternatives may per-
form under varying health conditions. In this study, 
the collection of oral fluid and serum samples as well 
as necropsies of pigs that died allowed for the iden-
tification or exclusion of critical pathogens, includ-
ing PRRSV, as influential factors in this group of 
pigs. Collection and testing of diagnostic samples, 
especially at the beginning and end of a study, can 
be used to assess and document pathogen exposure. 
If clinical signs of illness are observed, additional 
samples should be collected, based on the symptoms, 
to characterize the illness. Major changes in health 
status throughout a trial should be reported. Table 7 
outlines examples of potential pathogens of interest 
and methods of testing for them.
Determining pathogen presence, or the presence 
of agents/active infections, will involve identifying 
genetic material of a pathogen (generally through 
PCR), detecting an antigen (through ELISA or immu-
nohistochemistry), or detecting a viable pathogen 
Figure 3. Proposed necessary study components to be included and reported in studies evaluating alternatives to antibiotic growth promoters 
(AGP) for pigs. When critical information is included in reports of AGP alternative studies, the context of the study is better understood. This will 







/tas/article/2/3/298/5049815 by guest on 02 February 2021
308 Olsen et al.
Translate basic science to industry innovation
Table  7. Examples of methods for determining 
pathogen exposure in studies
Pathogen1 Sample to test Testing method2
PRRSV Oral fluids, or serum PCR, abELISA  
(or both)
PEDV Oral fluids PCR
Serum abELISA
PDCoV Oral fluids PCR







Porcine circovirus Oral fluids PCR
Serum abELISA, PCR
Mycoplasma hyorhinis Oral fluids PCR
Haemophilus parasuis Oral fluids PCR
Rotavirus Oral fluids PCR
TGEV/ PRCV Oral fluids PCR









E. coli Rectal swab Culture
Brachyspira Rectal swab Culture, PCR
Actinobacillus suis Nasal swab Culture, PCR
Streptococcus suis Lung Culture
1PRRSV  =  porcine reproductive and respiratory syndrome virus, 
PEDV = porcine epidemic diarrhea virus, PDCoV = porcine deltacor-
onovirus, IAV = influenza A virus, TGEV/PRCV = transmissible gas-
troenteritis virus/porcine respiratory coronavirus.
2PCR = polymerase chain reaction, abELISA = ELISA for antibody 
detection.
through isolation (Christopher-Hennings et al., 2012). 
Pathogen exposure is determined by measuring sero-
conversion, which confirms a prior infection or pres-
ence of a maternal antibody and is done by detecting 
antibody in the serum (Christopher-Hennings et al., 
2012). The specific procedure for defining health 
status via pathogen presence or exposure will likely 
depend on the nature of a study and the pathogens 
involved, and a strategy may need to be adapted for 
each study and pathogen of interest. It is also impor-
tant to report the medical treatment regimen used if  
pigs need to be treated for illness.
While it is important to confirm the presence 
of feed additives through diet analysis, it may not 
be possible to be fully quantitative in this respect, 
due perhaps to limitations of the assay, or due to 
transformation of the additive during the feed 
manufacturing process. In this study, analysis of 
feed samples for Bacillus spore counts revealed that 
a Bacillus product was included in the vitamin–
mineral premix that was used in the phase 1 and 2 
diets. Thus, the phase 1 and 2 diets all had greater 
spore counts than expected. Additionally, the spore 
counts in all the phase 1 and 2 diets were unexpect-
edly variable, and overall recovery was low (ranging 
from 20% to 50% in phase 1 and 2 diets; DR diets 
had an average recovery of 23% in phases 1 and 
2). This made it difficult to determine if  the DFM 
product was correctly added to the DR diets. It was 
clearer that the DFM product was added correctly 
in the phase 3 diets, although recovery of the prod-
uct was not as high as expected (roughly 30%) and 
may also point to variability or low recovery of the 
Bacillus assay in general.
To the authors’ knowledge, there is currently 
no assay readily available to analyze for the specific 
acids contained in the acid blend that was used in 
this experiment. Zinc levels in the ZA diets were 
slightly lower than expected but were much higher in 
the ZA as intended (Table 1). When considering the 
RS content of the potato starch product (approxi-
mately 78%, DM basis), the DR diet in phases 1 
and 2 showed only 62% recovery of expected values 
of RS. Since these were pelleted, the low recovery 
could be due to heat and water application dur-
ing the pelleting process, which can cause starch 
to gelatinize and increase its susceptibility to deg-
radation by alpha-amylase (Svihus and Zimonja, 
2011). When possible, it is crucial to analyze diets 
for the AGP alternatives being tested to confirm 
their presence as intended, as these outcomes can 
influence the interpretation of study results.
With future study design in mind, sample size 
calculations were conducted (Table 8) using the SD 
generated in the overall data to predict the sample 
size that would be needed to detect differences of 
practical significance and to determine if  required 
sample size would differ according to pig group 
size. Though group size may be an important con-
sideration in AGP alternative studies as previously 
discussed, it does not appear that a larger sample 
size would necessarily be needed for one pig group 
size over the other.
Table 8. Sample size calculations1
Variable Group size SD2 Effect size Sample size (n/trt)
ADG, kg 31 Pigs/pen 0.036 0.05 9
11 Pigs/pen 0.032 0.05 7
ADFI, kg 31 Pigs/pen 0.042 0.07 6
11 Pigs/pen 0.032 0.07 4
G:F 31 Pigs/pen 0.036 0.05 9
11 Pigs/pen 0.038 0.05 10
1α = 0.05; power = 0.80.
2Estimates of SD associated with each group size (31 or 11 pigs/pen) 
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In conclusion, the methodology used in this 
study resulted in the ability to compare the impact 
of dietary treatments on growth performance, 
morbidity, and medical treatments to establish a 
description of population health status. This was 
facilitated by careful planning and execution of 
the experimental protocol as well as strict record 
keeping and observation. The results suggest that 
group size is an important factor to consider when 
designing and interpreting AGP alternative stud-
ies. As research on AGP alternatives continues, 
the credibility and impact of future studies will be 
improved with proper design, protocol implemen-
tation, and consistent reporting of pertinent study 
information and results. Careful consideration of 
group size, sample size, the study components men-
tioned above, and how these factors may influence 
study outcomes will be advantageous to the swine 
industry’s rate of progress in identifying effective 
alternatives to growth-promoting antibiotics.
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